Research News

---

Topic: Chemotherapy (view all topics)

Tags for topic Chemotherapy:

• Abraxane (chemical name: paclitaxel)
• Adjuvant
• Adriamycin (chemical name: doxorubicin)
• Anthracyclines
• carboplatin (brand name: Paraplatin)
• Cytoxan (chemical name: cyclophosphamide)
• daunorubicin (brand names: Cerubidine, DaunoXome)
• Dose Dense
• Doxil (chemical name: doxorubicin)
• Ellence (chemical name: epirubicin)
• fluorouracil (also called 5-fluorouracil or 5-FU; brand name: Adrucil)
• Halaven (chemical name: eribulin)
• Ixempra (chemical name: ixabepilone)
• mitoxantrone (brand name: Novantrone)
• Navelbine (chemical name: vinorelbine)
• Neoadjuvant
• Standard
• Taxanes
• Taxol (chemical name: paclitaxel)
• Taxotere (chemical name: docetaxel)
• Xeloda (chemical name: capecitabine)

View articles by month and year

• Study Finds Scientific Basis for Chemo Brain

  Published on April 25, 2013 at 7:57 am

  • Tags: Memory loss, Standard, and Adjuvant

  A study has found a link between chemo brain and lower neuropsychological test scores.

• Chemo After Surgery for Locally Recurrent Breast Cancer Improves Survival

  Published on January 31, 2013 at 4:24 am

  • Tags: Standard and Adjuvant

  A study suggests that chemotherapy after surgery for locally recurrent breast cancer improves both disease-free survival and overall survival.

• Dose-Dense Ellence Regimen Better for High-Risk Breast Cancer Than Early-Stage Breast Cancer

  Published on December 20, 2012 at 5:14 am

  • Tags: Dose Dense, Ellence (chemical name: epirubicin), and Adjuvant

  Two studies looking at a dose-dense regimen of Ellence compared to a standard schedule found that the dose-dense regimen is better for high-risk breast cancer.

• Study Finds Physical Evidence That Chemo Brain is Real

  Published on December 17, 2012 at 9:57 am

  • Tags: Standard, Adjuvant, and Memory loss

  A study found that chemo brain is associated with changes in the way parts of the brain use glucose.

• Chemotherapy Slightly Ups Risk of Leukemia

  Published on December 16, 2012 at 5:59 am

  • Tags: Standard and Adjuvant

  Chemotherapy slightly increases the risk of leukemia later in life.

• Chemo Brain Seems to Start Before Chemotherapy Treatment, May Be Linked to Stress and Fatigue

  Published on December 16, 2012 at 4:41 am

  • Tags: Standard, Adjuvant, and Memory loss

  Chemo brain may be more closely linked to stress and fatigue than to chemotherapy according to a small study.

• Ginger May Help Ease Nausea Immediately After Chemotherapy

  Published on November 8, 2012 at 12:00 am

  • Tags: Standard, Cytoxan (chemical name: cyclophosphamide), Ellence (chemical name: epirubicin), Taxotere (chemical name: docetaxel), Adjuvant, and Nausea

  A small study suggests that adding ginger to standard anti-nausea medicines can reduce nausea in women diagnosed with advanced-stage breast cancer immediately after chemotherapy more than the anti-nausea medicines alone.

• Use of Anthracyclines to Treat Breast Cancer Has Gone Down

  Published on September 14, 2012 at 12:00 am

  • Tags: Anthracyclines, Taxanes, Standard, Abraxane (chemical name: paclitaxel), Adriamycin (chemical name: doxorubicin), daunorubicin (brand names: Cerubidine, DaunoXome), Doxil (chemical name: doxorubicin), Ellence (chemical name: epirubicin), mitoxantrone (brand name: Novantrone), Taxol (chemical name: paclitaxel), Taxotere (chemical name: docetaxel), and Adjuvant

  A study has found that after 2005, there was a large increase in taxane chemotherapy and a decrease in anthracycline chemotherapy to treat breast cancer in the United States.

• Zometa Seems to Reduce Recurrence Risk of Early-Stage Breast Cancer

  Published on September 26, 2011 at 12:00 am

  • Tags: Adjuvant

  A study suggests that Zometa after surgery may reduce the risk of recurrence and improve overall survival in postmenopausal women diagnosed with early-stage breast cancer.

• Zometa During and After Chemo Helps Keep Bones Strong

  Published on August 19, 2008 at 12:00 am

  • Tags: Standard and Adjuvant

  A small study shows that Zometa (chemical name: zoledronic acid) given during and after chemotherapy for early-stage breast cancer maintained bone health in pre-menopausal women.